Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISM trial of progesterone for threatened miscarriage
2014-002348-42Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in threatened abortion comparing Progesterone with Placebo (2 arms). Primary endpoint: Live birth beyond 34 completed weeks of gestation. Started Oct 2014; status: completed.
02
Drugs
progesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on 2014-002348-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002348-42.